natgillin/translations-raw huggingface dataset:
Caution should be exercised when
Pri sočasnem dajanju zdravila
Caution should be exercised when administering Bosulif concomitantly with proton pump inhibitors (PPIs).
Pri sočasni uporabi zdravila Bosulif skupaj z zaviralci protonske črpalke je potrebna previdnost.
Caution should be exercised when administering such products (e.g. midazolam, erythromycin, nifedipine), especially for those with a narrow therapeutic index (e.g. alfentanil, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus).
Pri sočasni uporabi teh zdravil (npr. midazolam, eritromicin, nifedipin) je potrebna previdnost, zlasti pri tistih z ozkim terapevtskim indeksom (npr. alfentanil, dihidroergotamin, ergotamin, fentanil, pimozid, kinidin, sirolimus, takrolimus).
Caution should be exercised when administering sugammadex to pregnant women.
Pri uporabi zdravila pri nosečnicah je potrebna previdnost.
Caution should be exercised when administering zidovudine to any patient (particularly obese women) with hepatomegaly, hepatitis or other known risk factors for liver disease and hepatic steatosis (including certain medicinal products and alcohol).
Pri dajanju zidovudina kateremu koli bolniku (še zlasti debelim bolnicam) s hepatomegalijo, hepatitisom ali z drugimi znanimi dejavniki tveganja za jetrno bolezen in jetrno steatozo (vključno z določenimi zdravil in alkoholom) je potrebna previdnost.
Caution should be exercised when administering zidovudine to any patient (particularly obese women) with hepatomegaly, hepatitis or other known risk factors for liver disease and hepatic steatosis (including certain medicinal products and alcohol).
Pri dajanju zidovudina kateremu koli bolniku (še zlasti debelim bolnicam) s hepatomegalijo, hepatitisom ali z drugimi znanimi dejavniki tveganja za jetrno bolezen in jetrno steatozo (vključno z določenimi zdravili in alkoholom) je potrebna previdnost.
Caution should be exercised when ataluren is co-administered with medicinal products that are inducers of UGT1A9 (e.g. mycophenolate mofetil), or inhibitors of BCRP (e.g. cyclosporine).
Kadar se ataluren uporablja sočasno z zdravili, ki so induktorji UGT1A9 (npr. mikofenolat mofetil) ali zaviralci BCRP (npr. ciklosporin), je potrebna previdnost.
Caution should be exercised when ataluren is co-administered with medicinal products that are substrates of UGT1A9, OAT1, OAT3, or OATP1B3 because of the risk of increase concentration of these medicinal products (eg, oseltamivir, acyclovir, ciprofloxacin, captopril, furosemide, bumetanide, valsartan, pravastatin, rosuvastatin, atorvastatin, pitavastatin).
Kadar se ataluren uporablja sočasno z zdravili, ki so substrati UGT1A9, OAT1, OAT3 ali OATP1B3, je potrebna previdnost, saj obstaja tveganje za zvišanje koncentracij teh zdravil (to so npr. oseltamivir, aciklovir, ciprofloksacin, kaptopril, furosemid, bumetanid, valsartan, pravastatin, rosuvastatin, atorvastatin in pitavastatin).
Caution should be exercised when ataluren is co-administered with medicinal products that are substrates or inducers of UGT1A9, inhibitors of BCRP, or substrates of OAT1, OAT3, or OATP1B3 (see section 4.5).
Previdnost je potrebna, kadar se ataluren uporablja sočasno z zdravili, ki so substrati ali induktorji UGT1A9, zaviralci BCRP ali substrati OAT1, OAT3 ali OATP1B3 (glejte poglavje 4.5).
Caution should be exercised when Avastin and intravenous bisphosphonates are administered simultaneously or sequentially.
Pri sočasnem ali zaporednem dajanju zdravila Avastin in intravenskih difosfonatov je potrebna previdnost.
Caution should be exercised when Bortezomib Hospira is combined with CYP3A4- or CYP2C19 substrates (see section 4.5).
Še posebna previdnost je potrebna, kadar se daje zdravilo Bortezomib Hospira v kombinaciji s substrati encima CYP3A4 ali CYP2C19 (glejte poglavje 4.5).
Caution should be exercised when both medicines are co-administered.
Med uporabo oeh zdravil je potrebna previdnost.
Caution should be exercised when co-administering Dynastat with warfarin and other oral anticoagulants (see section 4.5).
Pri sočasni uporabi zdravila Dynastat in varfarina ali drugih peroralnih antikoagulansov je potrebna previdnost (glejte poglavje 4.5).
Caution should be exercised when co-administering Tybost with pitavastatin.
Pri sočasnem dajanju zdravila Tybost s pitavastatinom je potrebna previdnost.
Caution should be exercised when combining celecoxib with warfarin and other oral anticoagulants (see section 4.5).
Previdnost je potrebna, kadar se celekoksib kombinira z varfarinom in drugimi peroralnimi antikoagulanti (glejte poglavje 4.5).
Caution should be exercised when considering belimumab therapy for patients with a history of malignancy or when considering continuing treatment in patients who develop malignancy.
Previdnost je potrebna pri odločanju za zdravljenje z belimumabom pri bolnikih z anamnezo malignoma in pri odločanju o nadaljnjem zdravljenju bolnikov, ki se jim pojavi malignom.
Caution should be exercised when considering the administration of Luminity to these patients.
Zato se morate za uporabo zdravila Luminity pri takšnih bolnikih odločiti previdno.
Caution should be exercised when considering the use of Cosentyx in patients with a chronic infection or a history of recurrent infection.
Pri odločanju za uporabo zdravila Cosentyx pri bolnikih s kronično okužbo ali z anamnezo ponavljajoče se okužbe je potrebna previdnost.
Caution should be exercised when considering the use of Inflectra in patients with chronic infection or a history of recurrent infections, including concomitant immunosuppressive therapy.
Pri odločanju o uporabi zdravila Inflectra pri bolnikih s kroničnimi okužbami ali ponavljajočimi se okužbami v pretekli anamnezi, pa tudi pri tistih, s sočasno imunosupresivno terapijo, je potrebna previdnost.
Caution should be exercised when considering the use of Remsima in patients with chronic infection or a history of recurrent infections, including concomitant immunosuppressive therapy.
Pri odločanju o uporabi zdravila Remsima pri bolnikih s kroničnimi okužbami ali ponavljajočimi se okužbami v pretekli anamnezi, pa tudi pri tistih, s sočasno imunosupresivno terapijo, je potrebna previdnost.
Caution should be exercised when considering the use of Simponi in patients with a chronic infection or a history of recurrent infection.
Pri odločanju, ali bi zdravilo Simponi uporabili pri bolnikih s kronično okužbo ali ponavljajočimi se okužbami v anamnezi, pa je potrebna previdnost.
Caution should be exercised when considering the use of STELARA in patients with a chronic infection or a history of recurrent infection (see section 4.3).
Ko razmišljate o uporabi zdravila STELARA pri bolnikih s kronično okužbo ali ponavljajočimi se okužbami v pretekli anamnezi, je potrebna previdnost (glejte poglavje 4.3).
Caution should be exercised when considering the use of sugammadex in patients receiving therapeutic anticoagulation for a pre-existing or co- morbid condition.
Pri odločitvi glede predpisovanja sugamadeksa bolnikom, ki se zdravijo z antikoagulanti zaradi druge predhodno obstoječe ali sočasne bolezni, je potrebna previdnost.
Caution should be exercised when initiating Entresto in patients with NYHA functional classification IV due to limited clinical experience in this population.
Zaradi majhnega obsega izkušenj v populaciji bolnikov, ki so po klasifikacij NYHA uvrščeni v funkcijski razred IV, je pri uvajanju zdravila Entresto tem bolnikom potrebna previdnost.
Caution should be exercised when initiating Neparvis in patients with NYHA functional classification IV due to limited clinical experience in this population.
Zaradi majhnega obsega izkušenj v populaciji bolnikov, ki so po klasifikacij NYHA uvrščeni v funkcijski razred IV, je pri uvajanju zdravila Neparvis tem bolnikom potrebna previdnost.
Caution should be exercised when initiating treatment with Xadago in patients with moderate hepatic impairment.
Ob začetku zdravljenja z zdravilom Xadago pri bolnikih z zmerno okvaro jeter je potrebna previdnost.
Caution should be exercised when Invirase/ritonavir and digoxin are co- administered.
Koncentracija triazolama je lahko povečana, kadar se sočasno daje z zdravilom Invirase/ritonavirjem.
Caution should be exercised when Invirase/ritonavir and digoxin are co- administered.
Pri sočasnem dajanju zdravila Invirase/ritonavirja z digoksinom je potrebna previdnost.
Caution should be exercised when patients previously given Simulect are re-exposed to a subsequent course of therapy with this medicinal product.
Kadar bolnike, ki so prej prejemali Simulect, pozneje ponovno izpostavimo zdravljenju s tem zdravilom, je potrebna previdnost.
Caution should be exercised when preparing liquid Ebilfumin for children and when administering Ebilfumin capsules or liquid Ebilfumin to children.
Pri pripravi tekočine zdravila Ebilfumin za otoke in kadar dajemo kapsule ali tekočino zdravila Ebilfumin otrokom, je potrebna previdnost.
Caution should be exercised when prescribing CIALIS to patients using potent CYP3A4 inhibitors (ritonavir, saquinavir, ketoconazole, itraconazole, and erythromycin) as increased tadalafil exposure (AUC) has been observed if the medicinal products are combined (see section 4.5).
Ko predpisujemo zdravilo CIALIS bolnikom, ki jemljejo močne zaviralce CYP3A4 (ritonavir, sakvinavir, ketokonazol, itrakonazol in eritromicin), je potrebna previdnost, ker so pri taki kombinaciji zdravil opažali povečano izpostavitev (AUC) tadalafilu (glejte poglavje 4.5).
Caution should be exercised when prescribing Cosentyx to patients with Crohn’s disease as exacerbations of Crohn’s disease, in some cases serious, were observed in clinical studies in both Cosentyx and placebo groups.
Pri predpisovanju zdravila Cosentyx bolnikom s Crohnovo boleznijo je potrebna previdnost, saj so v kliničnih študijah opažali izbruhe Crohnove bolezni, ki so bili v nekaterih primerih resni, pojavljali pa so se tako v študijskih skupinah z zdravilom Cosentyx kot v tistih s placebom.
Caution should be exercised when prescribing dalbavancin to patients with moderate or severe hepatic impairment (Child-Pugh B & C) as no data are available to determine appropriate dosing (see sections 5.2).
Previdnost je potrebna pri predpisovanju dalbavancina pacientom z zmerno ali hudo okvaro delovanja jeter (Child-Pugh B & C), ker ni ustreznih podatkov za določitev primernega odmerjanja (glejte poglavje 5.2).
Caution should be exercised when prescribing Kuvan to patients receiving treatment with levodopa.
Previdnost je potrebna kadar se zdravilo Kuvan predpisuje bolnikom, ki se zdravijo z levodopo.
Caution should be exercised when prescribing Kuvan to patients receiving treatment with levodopa.
Previdnost je priporočljiva, kadar se zdravilo Kuvan predpisuje bolnikom, ki se zdravijo z levodopo.
Caution should be exercised when prescribing nucleoside analogues to any patient (particularly obese women) with hepatomegaly, hepatitis or other known risk factors for liver disease and hepatic steatosis (including certain medicinal products and alcohol).
Pri predpisovanju nukleozidnih analogov je potrebna previdnost pri vseh bolnikih (zlasti ženskah s prekomerno telesno maso) s hepatomegalijo, hepatitisom ali drugimi znanimi dejavniki tveganja za bolezen jeter ter steatozo jeter (vključno z nekaterimi zdravili in alkoholom).
Caution should be exercised when prescribing nucleoside analogues to any patient (particularly obese women) with hepatomegaly, hepatitis or other known risk factors for liver disease.
Pri predpisovanju nukleozidnih analogov bolnikom (posebno debelim ženskam) s hepatomegalijo, hepatitisom ali z drugim znanim dejavnikom tveganja za jetrno bolezen je potrebna previdnost.
Caution should be exercised when prescribing Ranexa to patients:
Previdnost je potrebna pri predpisovanju zdravila Ranexa bolnikom:
Caution should be exercised when prescribing Renvela to patients also taking these medicinal products.
Pri predpisovanju zdravila Renvela bolnikom, ki jemljejo tudi omenjena zdravila, je potrebna previdnost.
Caution should be exercised when prescribing Sevelamer carbonate Zentiva to patients also taking these medicinal products.
Pri predpisovanju zdravila Sevelamer carbonate Zentiva bolnikom, ki jemljejo tudi omenjena zdravila, je potrebna previdnost.
Caution should be exercised when prescribing tadalafil to patients using potent CYP3A4 inhibitors (ritonavir, saquinavir, ketoconazole, itraconazole, and erythromycin) as increased tadalafil exposure (AUC) has been observed if the medicinal products are combined (see section 4.5).
Ko predpisujemo tadalafil bolnikom, ki jemljejo močne zaviralce CYP3A4 (ritonavir, sakvinavir, ketokonazol, itrakonazol in eritromicin), je potrebna previdnost, ker so pri taki kombinaciji zdravil opažali povečano izpostavitev (AUC) tadalafilu (glejte poglavje 4.5).
Caution should be exercised when prescribing tadalafil to patients using potent CYP3A4 inhibitors (ritonavir, saquinavir, ketoconazole, itraconazole, and erythromycin) as increased tadalafil exposure (AUC) has been observed if the medicinal products are combined (see section 4.5).
Ko predpisujemo zdravilo tadalafil bolnikom, ki jemljejo močne zaviralce CYP3A4 (ritonavir, sakvinavir, ketokonazol, itrakonazol in eritromicin), je potrebna previdnost, ker so pri taki kombinaciji zdravil opažali povečano izpostavitev (AUC) tadalafilu (glejte poglavje 4.5).
Caution should be exercised when prescribing Taltz to patients with inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, and patients should be monitored closely.
Previdnost je potrebna pri predpisovanju zdravila Taltz bolnikom z vnetno črevesno boleznijo, vključno s Crohnovo boleznijo in ulceroznim kolitisom, bolnike pa je treba skrbno spremljati.
Caution should be exercised when prescribing the vaccine to pregnant or breast-feeding women.
Pri predpisovanju cepiva nosečnicam ali doječim materam, je potrebna previdnost.
Caution should be exercised when prescribing to pregnant or breast-feeding women. (see section 4.6).
Pri predpisovanju cepiva nosečnicam ali doječim materam, je potrebna previdnost (glejte poglavje 4.6).
Caution should be exercised when prescribing to pregnant women.
Pri predpisovanju zdravila nosečnicam je potrebna previdnost.Pri predpisovanju zdravila nosečnicam je potrebna previdnost.
Caution should be exercised when prescribing TOBI Podhaler to patients with known or suspected neuromuscular disorders such as myasthenia gravis or Parkinson’s disease.
Pri predpisovanju zdravila TOBI Podhaler bolnikom z ugotovljeno živčno-mišično boleznijo, kot sta miastenija gravis ali Parkinsonova bolezen, ali s sumom na tako bolezen, je potrebna previdnost.
Caution should be exercised when prescribing TOBI Podhaler to patients with known or suspected renal dysfunction.
Pri predpisovanju zdravila TOBI Podhaler bolnikom z ugotovljeno ledvično disfunkcijo ali s sumom nanjo, je potrebna previdnost.
Caution should be exercised when rasagiline is administered to a breast-feeding mother.
Ob uporabi zdravila pri doječih materah je potrebna previdnost.
Caution should be exercised when Renagel is used in patients with difficulty swallowing.
Zato je pri teh bolnikih potrebna posebna previdnost pri uporabi zdravila Renagel.
Caution should be exercised when Renvela is used in patients with difficulty swallowing.
Zato je pri teh bolnikih potrebna posebna previdnost pri uporabi zdravila Renvela.
Caution should be exercised when Sevelamer carbonate Zentiva is used in patients with difficulty swallowing.
Zato je pri teh bolnikih potrebna posebna previdnost pri uporabi zdravila Sevelamer carbonate Zentiva.
Caution should be exercised when sevelamer hydrochloride is used in patients with difficulty swallowing.
Zato je pri teh bolnikih potrebna posebna previdnost pri uporabi sevelamerijevega klorida.
Caution should be exercised when switching combination therapy from regimens containing immunosuppressants, which interfere with MPA enterohepatic recirculation e.g. ciclosporin, to others devoid of this effect e.g. sirolimus, belatacept, or vice versa, as this might result in changes of MPA exposure.
Pri prehodu iz kombiniranega zdravljenja s shemo z imunosupresivi, ki ovirajo enterohepatični obtok mikofenolne kisline (npr. ciklosporin) na druge, ki nimajo takega učinka (npr. sirolimus, belatacept), ali obratno, je potrebna previdnost, saj to lahko vodi k spremembam izpostavljenosti mikofenolni kislini.
Caution should be exercised when the following active substances are administered concomitantly with levodopa therapy.
Previdnost je potrebna, kadar se sočasno z levodopo uporabljajo naslednje zdravilne učinkovine:
Caution should be exercised when therapy is administered to patients with pretreatment elevated transaminases (> the upper limit of the normal ranges and < 3 times the upper limit of the normal range);
Previdnost je potrebna pri predpisovanju bolnikom z zvišanimi vrednostmi aminotransferaz pred zdravljenjem (> zgornjo mejo normalnih vrednosti in ≤ 3-kratno zgornjo mejo normalnih vrednosti);
Caution should be exercised when therapy is prescribed for patients with hepatic injury risk factors e.g. obesity/overweight/non-alcoholic fatty liver disease, diabetes, substantial alcohol intake or concomitant medicinal products associated with risk of hepatic injury;
Previdnost je potrebna pri predpisovanju bolnikom s prisotnimi dejavniki tveganja za poškodbo jeter npr. debelost/prekomerna telesna masa/zamaščenost jeter nealkoholnega izvora, sladkorna bolezen, ter bolnikih, ki uživajo znatne količine alkohola ali sočasno jemljejo zdravila, ki jih spremlja tveganje za poškodbe jeter;
Caution should be exercised when Thymanax is administered to patients with pretreatment elevated transaminases (> the upper limit of the normal ranges and 3 times the upper limit of the normal range).
Pri bolnikih z zvišanimi vrednostmi aminotransferaz pred zdravljenjem (> zgornjo mejo normalnih vrednosti in  3-kratno zgornjo mejo normalnih vrednosti) je pri predpisovanju zdravila Thymanax potrebna previdnost.
Caution should be exercised when treating patients 80 years and older (see section 4.2).
Pri zdravljenju bolnikov, starih 80 let in več, je potrebna previdnost (glejte poglavje 4.2).
Caution should be exercised when treating patients with severe and end stage renal impairment (see section 5.2).
Pri zdravljenju bolnikov s hudo okvaro ledvic in končno odpovedjo ledvic je potrebna previdnost (glejte poglavje 5.2).
Caution should be exercised when treating patients ≥65 years of age with higher doses of Latuda.
Pri bolnikih, starih ≥ 65 let, je treba večje odmerke zdravila Latuda uporabljati previdno.
Caution should be exercised when treating such patients (see section 4.8, heading ‘Product-class-related adverse reactions’).
Pri zdravljenju takih bolnikov je potrebna previdnost (glejte poglavje 4.8, pod naslovom „Na skupino zdravil vezani neželeni učinki“).
Caution should be exercised when treating the elderly.
Pri zdravljenju starejših je potrebna posebna previdnost.
Caution should be exercised when using ONIVYDE in patients with body mass index <18.5 kg/m2.
Previdnost je potrebna pri uporabi zdravila ONIVYDE pri bolnikih z indeksom telesne mase < 18,5 kg/m2.
Caution should be exercised when using this product in patients over 75 years, due to the long half-life of the active substances and the limited experience in this population.
Pri uporabi tega zdravila pri bolnikih, starejših od 75 let, je potrebna previdnost zaradi dolgega razpolovnega časa zdravilnih učinkovin in omejenih izkušenj s to populacijo.
Caution should be exercised when Valdoxan is administered to patients with pretreatment elevated transaminases (> the upper limit of the normal ranges and 3 times the upper limit of the normal range).
Pri bolnikih z zvišanimi vrednostmi aminotransferaz pred zdravljenjem (> zgornjo mejo normalnih vrednosti in  3-kratno zgornjo mejo normalnih vrednosti) je pri predpisovanju zdravila Valdoxan potrebna previdnost.
Caution should be exercised when vemurafenib is co-administered with warfarin (CYP2C9) in patients with melanoma.
Kadar se vemurafenib pri bolnikih z melanomom uporabi hkrati z varfarinom (CYP2C9), je potrebna previdnost.
Caution should be exercised when verapamil is co- administered with REYATAZ.
Pri sočasni uporabi zdravila REYATAZ in verapamila je potrebna previdnost.
Caution should be exercised when verapamil is co- administered with REYATAZ/ritonavir.
Pri sočasni uporabi zdravila REYATAZ/ritonavirja in verapamila je potrebna previdnost.
Caution should be exercised when Xiapex is administered to a breast-feeding woman.
Pri dajanju zdravila Xiapex doječim ženskam je potrebna previdnost.
Caution should be exercised when ziconotide is administered to patients who are receiving systemic chemotherapy (see section 4.4).
Kadar je zikonotid apliciran bolnikom, ki prejemajo sistemsko kemoterapijo, je potrebna previdnost (glejte poglavje 4.4.).
Caution should be exercised when ziconotide is administered to patients who are receiving systemic chemotherapy (see section 4.5).
Kadar je zikonotid apliciran bolnikom, ki prejemajo sistemsko kemoterapijo, je potrebna previdnost (glejte poglavje 4.5.).
Caution should be exercised while breast-feeding during treatment with NutropinAq.
Med zdravljenjem z zdravilom NutropinAq je potrebna posebna previdnost med dojenjem.
Caution should be exercised with concomitant use of EXUBERA and such drugs.
Pri sočasni uporabi zdravila EXUBERA in takšnih zdravil je potrebna previdnost.
Caution should be exercised with escalation of Aranesp doses in patients with chronic renal failure.
Bolnikom s kronično odpovedjo ledvic je treba odmerke zdravila Aranesp povečevati previdno.
Caution should be exercised with escalation of Retacrit doses in patients with chronic renal failure, since high cumulative epoetin doses may be associated with an increased risk of mortality, serious cardiovascular and cerebrovascular events.
Pri višanju odmerkov zdravila Retacrit pri bolnikih s kronično ledvično odpovedjo je potrebna previdnost, ker so kumulativni odmerki epoetina lahko povezani s povečanim tveganjem za smrt ter resne kardiovaskularne in cerebrovaskularne dogodke.
Caution should be exercised with escalation of Retacrit doses in patients with chronic renal failure.
Pri višanju odmerkov zdravila Retacrit pri bolnikih s kronično ledvično okvaro je potrebna previdnost.
Caution should be exercised with escalation of Silapo doses in patients with chronic renal failure.
Pri višanju odmerkov zdravila Silapo pri bolnikih s kronično ledvično okvaro je potrebna previdnost.
Caution should be exercised with mild to moderate P-gp inhibitors (e.g. amiodarone, posaconazole, quinidine, verapamil and ticagrelor) (see sections 4.2 and 4.4).
Previdnost je potrebna pri blagih do zmernih zaviralcih P-gp (npr. amiodaronu, posakonazolu, kinidinu, verapamilu ali ticagrelorju) (glejte poglavji 4.2 in 4.4).
Caution should be exercised with respect to monitoring the incision for signs of infection in surgical patients receiving Dynastat.
Kirurškim bolnikom, zdravljenim z zdravilom Dynastat, je treba iz previdnosti nadzirati operacijsko rano glede na prisotnost znakov okužbe.
Caution should be exercised, dose reduction and/or additional drug level monitoring for P-gp substrate medicinal products with narrow therapeutic index (NTI) (e.g. digoxin, dabigatran etexilate, aliskiren) may be considered if these medicinal products are used concomitantly with vemurafenib (see section 4.5).
Če zdravila, ki so substrati P-gp in imajo ozko terapevtsko okno (npr. digoksin, dabigatran eteksilat, aliskiren), uporabljamo skupaj z vemurafenibom, je potrebna previdnost; razmisli se lahko o zmanjšanju odmerka in/ali dodatnem spremljanju koncentracije zdravila (glejte poglavje 4.5).
Caution should be exercised, including consideration of dose reduction, when co-administering Genvoya with tadalafil for the treatment of pulmonary arterial hypertension.
Pri sočasnem dajanju zdravila Genvoya s tadalafilom za zdravljenje pljučne arterijske hipertenzije je potrebna previdnost, vključo z razmislekom o zmanjšanju odmerka.